RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Clinical trial NCT03894215 · TERMINATED

Trial details

NCT number: NCT03894215
Sponsor: Agenus Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2019-06-01
Primary completion: 2025-03-26
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.